<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180417039344N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-10-11</date_registration>
      <primary_sponsor>Kulsum International Hospital</primary_sponsor>
      <public_title>Effects of pre-operative physiotherapy on subjects going for CABG</public_title>
      <acronym></acronym>
      <scientific_title>Effects of pre-operative physiotherapy on functional capacity, kinesiophobia and post operative ICU stay in subjects with Coronary artery disease (CAD) going for Coronary atrery bypass grafting (CABG)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-03-16</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/38915</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Health service research, Randomization description: Subjects will be randomly divided into two groups by using concealed envelope method, in which there will be two envelopes. One envelope will contain a piece of paper with control group written on it, while the other will have experimental group written on the piece of paper enclosed in. First participant will choose one envelope and will hand it over to the investigator, the investigator will open the envelope and will allocate the participant into the group mentioned in the envelope (e.g. experimental group) without letting the participant know about which group he/ she will belong to. The next participant will be considered to be in the other group (control group). Then the third will come and choose the envelope, and the same process will be followed again till last participant, Blinding description: There will be blinding of the care provider , they would not be informed about the participants of both groups. The outcome assessor will also be blinded regarding the type of intervention group the subject belongs to.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Coronary Artery Disease.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Subjects will be provided inspiratory muscle training, breathing exercises and also chest clearance techniques. Three sessions will be given of 30-40 minutes each prior to their surgery. Inspiratory muscle training will be direct gentle resistance in inward and upward direction below xiphoid process during inspiration. To enhance thoracic expansion, incentive spirometer will also be used. Chest clearance will be done by active cycle of breathing technique (ACBT) and manual therapeutic chest percussion. Intervention 2: Control Group: Subjects will be provided breathing exercises and also chest clearance techniques, 3 sessions of 30-40 minutes each.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Personal details would not be shared, although data related to study, outcomes and procedures will be shared.

When:
August 2019

To whom:
All the professionals working in clinical settings or in academia, undergraduate and post graduate students in the relevant field

Conditions:
Data would be shared for use for betterment of patients, and requests will be reviewed by investigators of the study

Where to obtain:
Via email to kiran_dpt.ahs@stmu.edu.pk

How to obtain:
kiran_dpt.ahs@stmu.edu.pk
An email with data sharing request to the mentioned mailing address will lead to sharing of data regarding the study

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Kiran Khushnood</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dar-ul-Shifa Campus, Street 3, H8/1</address>
        <city>Islamabad</city>
        <country1>Pakistan</country1>
        <zip>44000</zip>
        <telephone>+92 51 8441750</telephone>
        <email>kiran_dpt.ahs@stmu.edu.pk</email>
        <affiliation>Shifa Tameer-e-Millat University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Kiran Khushnood</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dar-ul-Shifa Campus, Street 3, H8/1</address>
        <city>Islamabad</city>
        <country1>Pakistan</country1>
        <zip>44000</zip>
        <telephone>+92 51 8441750</telephone>
        <email>kiran_dpt.ahs@stmu.edu.pk</email>
        <affiliation>Shifa Tameer-e-Millat University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Ejection Fraction of  ≥  25%
Exercise intensity of below anginal threshold
Able to perform 6 minute walk test
Able to tolerate mild to moderate activities</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Individuals with other systemic diseases
Previous surgical procedures
Subjects with any neurological or cognitive impairment</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I25</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Chronic ischemic heart disease</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Subjects will be provided inspiratory muscle training, breathing exercises and also chest clearance techniques. Three sessions will be given of 30-40 minutes each prior to their surgery. Inspiratory muscle training will be direct gentle resistance in inward and upward direction below xiphoid process during inspiration. To enhance thoracic expansion, incentive spirometer will also be used. Chest clearance will be done by active cycle of breathing technique (ACBT) and manual therapeutic chest percussion.</i_keyword>
      <i_keyword>Control Group: Subjects will be provided breathing exercises and also chest clearance techniques, 3 sessions of 30-40 minutes each</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Functional capacity. Timepoint: At baseline before physiotherapy session, then after 3 physiotherapy sessions, and again after surgical procedure. Method of measurement: By 6 minute walk test.</prim_outcome>
      <prim_outcome>Kinesiophobia. Timepoint: At baseline before physiotherapy session, then after 3 physiotherapy sessions, and again after surgical procedure. Method of measurement: Tampa scale of Kinesiophobia for heart.</prim_outcome>
      <prim_outcome>Cardiovascular and pulmonary endurance. Timepoint: At baseline before physiotherapy session, then after 3 physiotherapy sessions, and again after surgical procedure. Method of measurement: VO2 max and BORG scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Stay in ICU. Timepoint: After surgical procedure in ICU. Method of measurement: By measuring number of days a subject stays in ICU after surgical procedure.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kulsum International Hospital</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-03-08</approval_date>
        <contact_name>Ethical Committee, Kulsum International Hospital</contact_name>
        <contact_address>2020 Kulsum Plaza Islamabad Islamabad Capital Territory Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
